Aurora Sheboygan Pricing: Daratumumab 100 Milligrams Per 5 Milliliters Intravenous Solution at $370.31

Daratumumab is a monoclonal antibody medication primarily used in the treatment of multiple myeloma, a cancer of plasma cells. Administered intravenously, it targets specific proteins on cancer cells, enabling the immune system to attack and destroy them. At Aurora Medical Center Sheboygan County, the cost for a 100 milligrams per 5 milliliters intravenous solution of Daratumumab is $370.31. This fee typically covers the cost of the medication itself and may reflect the expenses involved in its research, development, and production. Patients should request an itemized estimate before treatment to clarify what is included in the price—such as drug preparation, administration, and potential facility fees—to avoid unexpected additional charges.

Cost Breakdown

• Daratumumab (100 mg/5 mL): $370.31 per unit
• Administration Fee: May be billed separately; confirm with provider
• Facility/Infusion Center Charges: Additional fees may apply depending on the facility
• Pre-medications or Labs: Sometimes required prior to infusion—costs vary

Associated Costs to Consider

• Physician consultation fees
• Blood tests and monitoring during therapy
• Other medications (e.g., to prevent infusion reactions)
• Follow-up visits and assessments

Insurance & Payment Advice

• Contact your insurance provider in advance to verify Daratumumab coverage, co-pays, and pre-authorization requirements.
• Ask the facility about financial assistance programs or payment plans if you are uninsured or underinsured.
• Request a comprehensive, itemized estimate for the full course of treatment, not just the drug itself.

Side Effect & Recovery Considerations

• Common side effects may include infusion reactions, fatigue, respiratory symptoms, or low blood counts.
• Plan for possible extended observation during initial infusions, as reactions are most likely with the first dose.
• Discuss supportive care and symptom management options with your care team ahead of treatment.

Frequently Asked Questions

• What is Daratumumab used for?
  Daratumumab is primarily used for treating multiple myeloma, a type of cancer affecting plasma cells in the bone marrow.
• How is Daratumumab administered?
  It is given as an intravenous infusion, meaning it is delivered directly into your bloodstream in a clinical setting.
• Does the $370.31 fee cover the entire treatment?
  No, this fee is for one unit of Daratumumab (100 mg/5 mL). Additional costs such as infusion, facility, and monitoring fees are usually billed separately.
• Will my insurance cover Daratumumab?
  Coverage varies widely by plan. Always check with your insurer about coverage, co-pays, and pre-authorization before starting therapy.
• Are there financial assistance options if I can’t afford treatment?
  Many hospitals and drug manufacturers offer financial aid or payment plans. Ask your provider or social worker for available resources.
• Are there side effects I should be aware of?
  Yes, common side effects include infusion reactions, fatigue, respiratory symptoms, and low blood counts. Your care team will monitor for these and provide management strategies.
• How many infusions will I need?
  The number of infusions depends on your specific treatment plan and response to therapy. Ask your oncologist for a schedule tailored to your condition.
• How can I minimize out-of-pocket costs?
  Request an itemized estimate, confirm insurance coverage, and ask about assistance programs to reduce unexpected expenses.
• What should I bring or prepare for my infusion appointment?
  Bring your insurance information, a list of current medications, and something to help pass the time, as infusions can take several hours. Arrange transportation if feeling unwell post-infusion.
• Can Daratumumab be combined with other treatments?
  Yes, it is often part of a combination therapy for multiple myeloma. Your healthcare provider will determine the best regimen for you.
• What follow-up is required after my infusion?
  Regular blood tests and clinic visits are typically needed to monitor your response and manage side effects.

Aurora Medical Center Sheboygan County offers a range of medical services, including specialized treatments such as the intravenous administration of Daratumumab. Daratumumab is a monoclonal antibody used primarily in the treatment of multiple myeloma, a type of blood cancer. It works by targeting and binding to a specific protein on the surface of cancer cells, helping the immune system to identify and destroy them. At Aurora Sheboygan, the cost for Daratumumab 100 Milligrams Per 5 Milliliters Intravenous Solution is priced at $370.31, reflecting the center’s commitment to providing advanced cancer therapies at competitive rates.

What is Daratumumab used for? – Daratumumab is primarily used for the treatment of multiple myeloma, a cancer of plasma cells, and it helps in slowing down the progression of this disease.

How is Daratumumab administered? – Daratumumab is administered as an intravenous solution, meaning it is given directly into the bloodstream through a vein, typically in a clinical setting.

Why is Daratumumab priced at $370.31? – The price of $370.31 for Daratumumab reflects the cost of the medication itself, which includes the research, development, and manufacturing processes involved in producing this advanced cancer treatment.

Are there any side effects associated with Daratumumab? – Yes, some common side effects of Daratumumab include infusion-related reactions, fatigue, nausea, back pain, fever, and cough, though patients should discuss any concerns with their healthcare provider.

Is Daratumumab covered by insurance? – Coverage for Daratumumab can vary depending on the patient’s insurance plan, and it is advisable for patients to check with their insurance provider to understand their specific coverage options.

How effective is Daratumumab in treating multiple myeloma? – Clinical studies have shown that Daratumumab can be effective in reducing the progression of multiple myeloma and improving survival rates, particularly when used in combination with other treatments.

Can Daratumumab be used for other conditions? – While primarily used for multiple myeloma, ongoing research is exploring the potential use of Daratumumab in treating other conditions, but its use should always be guided by a healthcare professional.